9/30
08:38 am
adil
Adial Pharmaceuticals (NASDAQ:ADIL) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $1.50 price target on the stock.
Medium
Report
Adial Pharmaceuticals (NASDAQ:ADIL) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $1.50 price target on the stock.
9/30
08:30 am
adil
Rating for ADIL
Low
Report
Rating for ADIL
9/30
07:40 am
adil
Adial Pharmaceuticals upgraded to Buy from Hold at Maxim
Low
Report
Adial Pharmaceuticals upgraded to Buy from Hold at Maxim